Polar Capital Holdings PLC Harmony Biosciences Holdings, Inc. Transaction History

Polar Capital Holdings PLC

  • $16.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$45.4 - $60.91 $7.95 Million - $10.7 Million
-175,000 Reduced 24.67%
534,325 $29.4 Million
Q3 2022

Nov 14, 2022
SELL
$42.06 - $55.45 $5.13 Million - $6.76 Million
-122,000 Reduced 14.68%
709,325 $31.4 Million
Q2 2022

Aug 15, 2022
BUY
$33.54 - $52.15 $9.44 Million - $14.7 Million
281,325 Added 51.15%
831,325 $40.5 Million
Q1 2022

May 16, 2022
BUY
$33.14 - $51.13 $18.2 Million - $28.1 Million
550,000 New
550,000 $26.8 Million

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.1M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email